Eli Lilly & Co. (LLY): Price and Financial Metrics

LLY POWR Grades

• LLY scores best on the Quality dimension, with a Quality rank ahead of 92.43% of US stocks.
• The strongest trend for LLY is in Quality, which has been heading down over the past 51 weeks.
• LLY ranks lowest in Momentum; there it ranks in the 18th percentile.

LLY Stock Summary

• LLY has a market capitalization of $226,413,131,564 -- more than approximately 99.17% of US stocks.
• With a one year PEG ratio of 408.17, ELI LILLY & Co is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 92.69% of US stocks.
• ELI LILLY & Co's stock had its IPO on January 1, 1986, making it an older stock than 92.68% of US equities in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to ELI LILLY & Co are PFE, MRK, TXN, INTC, and ABBV.
• LLY's SEC filings can be seen here. And to visit ELI LILLY & Co's official web site, go to www.lilly.com.

LLY Valuation Summary

• LLY's price/earnings ratio is 40.7; this is 11.51% higher than that of the median Healthcare stock.
• Over the past 243 months, LLY's price/earnings ratio has gone up 13.
• LLY's price/earnings ratio has moved up 13 over the prior 243 months.

Below are key valuation metrics over time for LLY.

LLY Growth Metrics

• The 4 year price growth rate now stands at 103.4%.
• The 3 year cash and equivalents growth rate now stands at -11.75%.
• Its 2 year net income to common stockholders growth rate is now at 392.24%.

Over the past 15 months, LLY's revenue has gone up $3,639,200,000.

The table below shows LLY's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	26,726.3	7,094.7	6,070.7
2021-03-31	25,485.6	7,814.6	6,092.5
2020-12-31	24,539.8	6,499.6	6,193.7
2020-09-30	23,213.8	6,648.1	5,572.6
2020-06-30	22,949.8	6,351.6	5,618.1
2020-03-31	23,087.1	4,907.7	5,533.3

LLY's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• LLY has a Quality Grade of B, ranking ahead of 92.36% of graded US stocks.
• LLY's asset turnover comes in at 0.577 -- ranking 64th of 681 Pharmaceutical Products stocks.
• MRK, BHC, and NBY are the stocks whose asset turnover ratios are most correlated with LLY.

The table below shows LLY's key quality metrics over time.